Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ezzet

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 23, 1998
The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol)M van Vugt, F Ezzet, L Phaipun, et al.
European Journal of Clinical Pharmacology|September 29, 2000
Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteersM Bindschedler, G Lefèvre, F Ezzet, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 23, 2000
Pharmacokinetic interaction trial between co-artemether and mefloquineG Lefèvre, M Bindschedler, F Ezzet, et al.
Clinical Therapeutics|July 7, 2001
A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibeF Ezzet, G Krishna, D B Wexler, et al.
Biopharmaceutics & Drug Disposition|May 30, 1998
The effect of age on the pharmacokinetics of valsartanA Sioufi, F Marfil, A Jaouen, et al.
The American Journal of Tropical Medicine and Hygiene|February 16, 2000
No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrineM van Vugt, F Ezzet, F Nosten, et al.
Biopharmaceutics & Drug Disposition|August 1, 1997
Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administrationA Sioufi, N Sandrenan, J Godbillon, et al.
Clinical Pharmacology and Therapeutics|June 15, 2001
Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis CJ F Jen, P Glue, F Ezzet, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1992
The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjectsP F Trunet, P Mueller, F Girard, et al.
Journal of Clinical Pharmacology|September 11, 2001
The plasma concentration and LDL-C relationship in patients receiving ezetimibeF Ezzet, D Wexler, P Statkevich, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 23, 1998
The relationship between capillary and venous concentrations of the antimalarial drug lumefantrine (benflumetol)M van Vugt, F Ezzet, L Phaipun, et al.
European Journal of Clinical Pharmacology|September 29, 2000
Cardiac effects of co-artemether (artemether/lumefantrine) and mefloquine given alone or in combination to healthy volunteersM Bindschedler, G Lefèvre, F Ezzet, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 23, 2000
Pharmacokinetic interaction trial between co-artemether and mefloquineG Lefèvre, M Bindschedler, F Ezzet, et al.
Clinical Therapeutics|July 7, 2001
A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibeF Ezzet, G Krishna, D B Wexler, et al.
Biopharmaceutics & Drug Disposition|May 30, 1998
The effect of age on the pharmacokinetics of valsartanA Sioufi, F Marfil, A Jaouen, et al.
The American Journal of Tropical Medicine and Hygiene|February 16, 2000
No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrineM van Vugt, F Ezzet, F Nosten, et al.
Biopharmaceutics & Drug Disposition|August 1, 1997
Comparative bioavailability of letrozole under fed and fasting conditions in 12 healthy subjects after a 2.5 mg single oral administrationA Sioufi, N Sandrenan, J Godbillon, et al.
Clinical Pharmacology and Therapeutics|June 15, 2001
Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis CJ F Jen, P Glue, F Ezzet, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1992
The effects of fadrozole hydrochloride on aldosterone secretion in healthy male subjectsP F Trunet, P Mueller, F Girard, et al.
Journal of Clinical Pharmacology|September 11, 2001
The plasma concentration and LDL-C relationship in patients receiving ezetimibeF Ezzet, D Wexler, P Statkevich, et al.
Pageof 2